Lv1
80 积分 2024-07-07 加入
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
2个月前
已完结
When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy
5个月前
已完结
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases
5个月前
已完结
Malignancy-associated haemophagocytic lymphohistiocytosis
5个月前
已完结
Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis
6个月前
已完结
Treatment of systemic juvenile idiopathic arthritis
8个月前
已完结
Kidney immunology from pathophysiology to clinical translation
9个月前
已完结
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy
9个月前
已关闭
OP0207 EFFICACY AND SAFETY OF EMAPALUMAB IN PATIENTS WITH MACROPHAGE ACTIVATION SYNDROME IN STILL'S DISEASE: RESULTS FROM A POOLED ANALYSIS OF TWO PROSPECTIVE TRIALS
9个月前
已关闭
Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome
10个月前
已完结
皖公网安备34019202002308
